MedTrace Logo

Substance Use and Eating Disorders : Food Craving and Addiction Transfer

NCT05315635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2024-06-18

No results posted yet for this study

Summary

Substance Use Disorder (SUD) and Eating Disorders (ED) are severe and persistent disturbances that are associated with significant harm. These two disorders have many clinical similarities, including craving and behavioral loss of control. Recently, craving for food has been described in newly abstinent patients with SUD. the aim of the study is to verify the hypothesis of addiction transfer based on common neurobiological mechanisms between substance craving and food craving, that postulates that food craving would correspond to an attempt to regulate substance craving (or vice versa).

Conditions

Interventions

OTHER

Questionnaire

Patients treated for substance use disorders and patients treated for eating disorders will have to complete self-questionnaires and a clinical psychiatric (MINI) at the inclusion. Patients suffering from substance use disorder will be assessed 3 weeks after inclusion. Questionnaires are : * Modified Yale Food Addiction (mYFAS 2.0) and Impulsive Behavior Scale (UPPS-P) * Trait Meta-Mood Scale (TMMS), Hospital Anxiety and Depression Scale (HADs), Emotional Appetite Questionnaire (EMAQ), Perceived Stress Scale (PSS-10), Multidimensional Assessment of Interoceptive Awareness (MAIA) and Five Facet Mindfulness Questionnaire (FFMQ) * Mini International Neuropsychiatric Interview (MINI), Eating Disorder Examination-Questionnaire (EDE-Q), Rosenberg's Self Esteem (RSE) and Ruminative Response Scale for Eating disorders (RRS-ED) * Pittsburgh Sleep Quality Index (PSQI) and Montreal Cognitive Assessment (MoCA)

Sponsors & Collaborators

  • Centre Hospitalier Charles Perrens, Bordeaux

    lead OTHER_GOV

Principal Investigators

  • Mélina FATSEAS, Prof, MD · Physician

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-03-01
Completion
2024-04-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05315635 on ClinicalTrials.gov